Business
Phase II study for indication expansion of TLX250-CDx doses
Phase II study for indication expansion of TLX250-CDx doses
About this update from Telix Pharmaceuticals Limited
[{"type":"text","content":"Telix Pharmaceuticals Ltd has released a press release. View Attachment","length":254,"tagName":"div"}]